O'Neil Shaun 4
4 · PAVmed Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
PAVmed (PAVM) COO Shaun O'Neil Receives Restricted Stock Award
What Happened
- Shaun O'Neil, Chief Operating Officer of PAVmed Inc. (PAVM), received a grant of 110,000 restricted common shares on April 2, 2026. The shares were granted at $0.00 per share (no cash exchanged), reflecting an equity compensation award rather than an open‑market purchase.
Key Details
- Transaction date: 2026-04-02; Filing date: 2026-04-03 (filed the next day).
- Grant: 110,000 restricted shares at $0.00 per share; total reported value $0 (compensation award).
- Vesting: Single vesting date of May 20, 2029; shares subject to forfeiture if requisite service period not completed (per footnote).
- Shares owned after transaction: not specified in the provided filing excerpt.
- No indication of a 10b5-1 plan, sale, exercise, gift, or tax withholding reported in this transaction.
Context
- This is a typical executive equity award (restricted stock) used for compensation and retention. Because the award vests only after a multi‑year service period, it is not an immediate purchase signal for the market and will only convert to tradable shares if vesting and any company conditions are met.
Insider Transaction Report
Form 4
PAVmed Inc.PAVM
O'Neil Shaun
Chief Operating Officer
Transactions
- Award
Common Stock
[F1]2026-04-02+110,000→ 115,598 total
Footnotes (1)
- [F1]Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Signature
/s/ Michael A. Gordon, by power of attorney|2026-04-02